Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona C McKay

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Differences in common heritable blood immune cell populations may underlie MS susceptibility and progressionDavid R Booth, Nicole L Fewings, Grant P Parnell, et al.
Plos One|October 23, 2013
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependentFiona C McKay, Edwin Hoe, Grant Parnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2010
Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cellsEdwin Hoe, Fiona C McKay, Stephen D Schibeci, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 22, 2008
BAFF is a biological response marker to IFN-beta treatment in multiple sclerosisKaushal S Gandhi, Fiona C McKay, Stephen D Schibeci, et al.
Journal of Autoimmunity|April 15, 2008
CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisFiona C McKay, Louisa I Swain, Stephen D Schibeci, et al.
Plos One|May 14, 2010
Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosisKaushal S Gandhi, Fiona C McKay, Eve Diefenbach, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2008
Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activationJason D McArthur, Fiona C McKay, Vidiya Ramachandran, et al.
Human Molecular Genetics|October 26, 2013
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cellsFernando Shahijanian, Grant P Parnell, Fiona C McKay, et al.
Genes and Immunity|June 24, 2021
Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditionsSamantha P L Law, Prudence N Gatt, Stephen D Schibeci, et al.
Genome Medicine|May 2, 2019
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibilityAli Afrasiabi, Grant P Parnell, Nicole Fewings, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Differences in common heritable blood immune cell populations may underlie MS susceptibility and progressionDavid R Booth, Nicole L Fewings, Grant P Parnell, et al.
Plos One|October 23, 2013
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependentFiona C McKay, Edwin Hoe, Grant Parnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 26, 2010
Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cellsEdwin Hoe, Fiona C McKay, Stephen D Schibeci, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 22, 2008
BAFF is a biological response marker to IFN-beta treatment in multiple sclerosisKaushal S Gandhi, Fiona C McKay, Stephen D Schibeci, et al.
Journal of Autoimmunity|April 15, 2008
CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisFiona C McKay, Louisa I Swain, Stephen D Schibeci, et al.
Plos One|May 14, 2010
Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosisKaushal S Gandhi, Fiona C McKay, Eve Diefenbach, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2008
Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activationJason D McArthur, Fiona C McKay, Vidiya Ramachandran, et al.
Human Molecular Genetics|October 26, 2013
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cellsFernando Shahijanian, Grant P Parnell, Fiona C McKay, et al.
Genes and Immunity|June 24, 2021
Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditionsSamantha P L Law, Prudence N Gatt, Stephen D Schibeci, et al.
Genome Medicine|May 2, 2019
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibilityAli Afrasiabi, Grant P Parnell, Nicole Fewings, et al.
Pageof 3